HIGHFDA DEVICE

ESAOTE Endocavity Ultrasonic Probe E 3-12 Recall Affects 5 Units (2025)

ESAOTE recalled 5 Endocavity Ultrasonic Probe E 3-12 units sold in the United States to healthcare providers in NC and TX. A potential weakness in the probe body could cause liquid to leak from the terminal part of the casing near the cable. Healthcare providers and patients should stop using the device immediately and follow manufacturer instructions.

Official notice
ESAOTEHealth & Personal CareMedical DevicesE 3-12120000038UDI 0805604453891

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
March 14, 2025
Status
TERMINATED
Severity
7/10

Quick Facts at a Glance

Recall Date
March 14, 2025
Hazard Level
HIGH
Brand
ESAOTE
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
ESAOTE
Product type
Endocavity Ultrasonic Probe
Model numbers
E 3-12, 120000038, UDI 0805604453891, 241700533C, 241700529C, 241700607C, 241700536C, 241700613C
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 14, 2025

  2. Reported by FDA DEVICE

    March 11, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

A potential weakness has been identified in the probe body, so that, in a specific production batch, liquid may leak from the terminal part of the casing near the cable.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact ESAOTE S.P.A. or your healthcare provider for instructions. Notification method: Letter

About This Product

The ESAOTE Endocavity Ultrasonic Probe E 3-12 is used in ultrasound imaging with endocavity applications. Healthcare facilities rely on these probes for diagnostic procedures.

Why This Is Dangerous

A weakness in the probe body can allow liquid to leak from the terminal area near the cable. Liquid exposure can pose electrical and chemical risks during use.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Only 5 units were involved with US distribution in NC and TX. The risk is contingent on usage and exposure to the leaked liquid.

Practical Guidance

How to identify if yours is affected

  1. Locate the device label for Model E 3-12 and REF 120000038.
  2. Check UDI 0805604453891 on the device packaging or label.
  3. If a match is found, stop using the device immediately.

Where to find product info

Recall notices are available through ESAOTE and the FDA enforcement page linked in the recall notice.

What timeline to expect

Typical recall remediation timelines vary; hospitals usually process replacements within weeks. The data does not specify exact timing for refunds or替

If the manufacturer is unresponsive

  • Escalate to hospital risk management or biomedical engineering.
  • File a formal complaint with ESAOTE and consult your regulatory body if needed.

How to prevent similar issues

  • Verify model, REF, UDI, and serial numbers before using ultrasound probes.
  • Buy from authorized distributors.
  • Schedule routine device recalls checks with biomedical engineering staff.

Documentation advice

Keep recall notice, serial numbers, UDI, and all correspondence. Document the steps taken to remove affected devices from service.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model: E 3-12 Reference: REF 120000038 UDI: 0805604453891 Serial numbers: 241700533C, 241700529C, 241700607C, 241700536C, 241700613C Where sold: United States, nationwide with distribution to NC and TX When sold: Recall dated 2025-03-14 Estimated quantity: 5 units Price: Unknown

Key Facts

  • US distribution in NC and TX

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Brand
Model Numbers
E 3-12
120000038
UDI 0805604453891
241700533C
241700529C
+3 more
Affected States
ALL
Report Date
March 11, 2026
Recall Status
TERMINATED

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more